Related Experiment Video
Updated: Aug 3, 2026
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Summary
Lung carcinoma patients exhibit higher tyrosinase activity and reduced inhibitory factors in their serum compared to healthy individuals. These findings highlight potential biomarkers for lung cancer detection.
Area of Science:
- Biochemistry
- Oncology
- Medical Diagnostics
Background:
- Tyrosinase is a key enzyme in melanin production.
- Altered enzyme activity is often associated with various diseases, including cancers.
- Investigating serum enzyme profiles can offer insights into disease states.
Purpose of the Study:
- To compare serum tyrosinase activity and inhibitory factors between lung carcinoma patients and normal individuals.
- To identify potential diagnostic markers for lung carcinoma.
Main Methods:
- Serum samples were collected from lung carcinoma patients and healthy controls.
- Tyrosinase activity in serum was measured.
- Serum tyrosinase inhibitory factors were analyzed.
Main Results:
- Lung carcinoma patients demonstrated significantly increased serum tyrosinase activity compared to normal individuals.
- Seven distinct serum enzymic fractions or carriers were identified in patients with lung carcinoma.
- A general decrease in serum tyrosinase inhibitory factors was observed in lung carcinoma patients.
Conclusions:
- Elevated tyrosinase activity and reduced inhibitory factors in serum are characteristic of lung carcinoma.
- Serum tyrosinase may serve as a potential biomarker for the diagnosis of lung carcinoma.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019